Abstract:Abstract Background: The chemokine (C-X3-C motif) ligand 1 (CX3CL1), also called fractalkine (FKN), has recently been reported to be involved in osteoclastogenic process and pathological bone destruction. Objective: This study aimed to investigate the link between serum CX3CL1/FKN levels with disease progression of postmenopausal osteoporotic patients. Methods: A total of 53 women with postmenopausal osteoporosis (PMOP group), 51 postmenopausal non-osteoporotic female patients (PMNOP group) and 50 premenopausal non-osteoporotic healthy women of childbearing age (control group) were enrolled in the study. The bone mineral density (BMD) for all subjects was determined via dual-energy X-ray absorptiometry of the lumbar spine, femoral neck, internal trochanter, total hip, greater trochanter and Ward’s triangle. The levels of FKN in the serum were examined using the enzyme-linked immunosorbent assay method. The serum bone resorption markers TRACP-5b, NTX levels, inflammation markers IL-1β and IL-6 as well as oestrogen-2(E2) were also detected in all participants. The visual analogue scores (VAS) and Oswestry Disability Index (ODI) for low back pain were recorded in PMOP females for evaluation of osteoporotic pain and function. Results: FKN levels were significantly higher in postmenopausal osteoporotic patients compared with postmenopausal non-osteoporotic females (139.8 ± 44.3 pg/mL VS 116.5 ± 23.1 pg/mL, p < 0.05) and healthy controls (139.8 ± 44.3 pg/mL VS 109.7 ± 19.4 pg/mL, p < 0.05). Serum FKN concentrations were negatively associated with BMD at femoral neck (r = −0.394, p = 0.004), total hip(r = −0.374, p = 0.006), internal trochanter(r = −0.340, p = 0.013), greater trochanter(r = −0.376, p = 0.006), Ward’s triangle(r = −0.343, p = 0.012), L1–L4 lumbar spine(r = −0.339, p = 0.013) and positively associated with VAS (r = 0.321, p = 0.019) and ODI (r = 0.377, p = 0.005) scores, bone turnover makers (TRACP-5b:r = 0.341, p = 0.012; NTX:r = 0.364, p = 0.007)as well as inflammation markers (IL-1β: r = 0.396, p = 0.003; IL-6:r = 0.355, p = 0.009) in postmenopausal osteoporotic patients. Conclusions: Serum FKN may serve as a novel biomarker for assessing disease progression and a new potential therapeutic target for anti-resorptive treatment in osteoporosis patients.

[Correlation Between Follicle-Stimulating Hormone and Total Procollagen I N-terminal Propeptide in Perimenopausal Women].

Correlation analysis for follicle-stimulating hormone and C-terminal cross-linked telopetides of type i collagen in menopausal transition women with osteoporosis

SERUM C-C MOTIF LIGAND 11/EOTAXIN-1 MAY SERVE AS A CANDIDATE BIOMARKER FOR POSTMENOPAUSAL OSTEOPOROSIS

Intestinal Microecology And Expressions Of Serum Fibroblast Growth Factors In Women With Postmenopausal Osteoporosis

[Women with Poor Response to Ovarian Stimulation Have Increased Follicular Bone Morphogenetic Protein-15 Levels].

Serum CX3CL1/fractalkine Concentrations Are Positively Associated with Disease Severity in Postmenopausal Osteoporotic Patients.

The Relationship Between the Levels of Gonadotropic Hormones and Opg, Leptin, Tgf-Beta 1 and Tgf-Beta 2 in Chinese Adult Women

Association of Serum Follicle Stimulating Hormone with Osteoprotegerin, Leptin, TGF-β1, and TGF-β2 in Women

Relationship of serum follitropin level with bone mineral density and prevalence of osteoporosis in Changsha women

Bone turnover alterations across the menopausal transition in south-eastern Chinese women [corrected]

Relation of reproductive hormones and serum osteocalcin with perimenopausal and child-bearing women

Relationship of age-related concentrations of serum FSH and LH with bone mineral density, prevalence of osteoporosis in native Chinese women.

Relationship of Age-related Levels of Serum Sex Hormones with Bone Metabolism Markers in Women

Follicle-Stimulating Hormone Increases the Risk of Postmenopausal Osteoporosis by Stimulating Osteoclast Differentiation

Age-related changes in biochemical markers of bone turnover and gonadotropin levels and their relationship among Chinese adult women

Association of follicle-stimulating hormone with bone turnover markers and bone mineral density in Chinese women across the menopausal transition.

Relationships between Follicle-Stimulating Hormone and Adiponectin in Postmenopausal Women

Association of Follicle-Stimulating Hormone with Lipid Profiles in Older Women: a Cross-Sectional SPECT-China Study.

An independent positive relationship between the serum total osteocalcin level and fat-free mass in healthy premenopausal women.

Follicle-stimulating Hormone and Lipid Profile in Women Older than 55

Re-analysis of serum procollagen type 1 N-terminal propeptide andβcross-linked C-telopeptide of typeⅠcollagen concentrations in healthy men and women of Han nationality